Related Experiment Video
Updated: May 23, 2026

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Published on: June 16, 2022
Isobavachin inhibits osteoclastogenesis in inflammatory osteolysis loss by modulating the ROS-mediated Nrf2/HO-1
Liang Liao1,2,3, Yunde Xu1,2, Jindeng Liao1,2
1Department of Traumatic Orthopedics and Hand Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.
Objectives:
Isobavachin (Ibv), a monomeric compound derived from a traditional Chinese herb, demonstrates a range of biological activities. However, the precise effects of Ibv on inflammatory osteolysis remain inadequately understood. The present study seeks to elucidate the mechanisms underlying Ibv's inhibitory effects on osteoclasts (OCs) differentiation and inflammatory osteolysis.
Methods:
The CCK-8 assay assessed cell viability with Ibv treatment, while tartrate acid phosphatase staining, podosome belt staining, and bone resorption assays evaluated Ibv's impact on OCs differentiation and OCs function. PCR and Western blot analyses were conducted to assess the expression of key genes and proteins. The model of inflammatory osteolysis induced by lipopolysaccharide was utilized.
Key Findings:
Ibv significantly inhibits OCs differentiation besides suppressing lipopolysaccharide-induced inflammatory osteolysis. micro-computed tomography analysis demonstrated that Ibv treatment markedly improved bone microarchitecture. Ibv hinders OCs formation and activation by downregulating TRAF6 and enhancing NRF2 expression, lowering ROS levels in OCs. This modulation further impeded the downstream NF-κB and MAPK pathways, ultimately suppressing bone resorption.
Conclusions:
The present study highlights Ibv's capacity to restrain OCs differentiation and inflammatory osteolysis, imposing its probability as a therapeutic agent for conditions. The proposed mechanism of action encompasses the regulation of the ROS/NF-κB and MAPK pathways, establishing a conceptual basis for the advancement of Ibv in therapeutic applications.
Related Concept Videos
Osteoclasts in Bone Remodeling
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
TGF - β Signaling Pathway
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Bone Remodeling